PharmaCorp Rx Inc. (TSXV:PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.4700
-0.0050 (-1.05%)
Sep 3, 2026, 2:20 PM EST

PharmaCorp Rx Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
827663412-
Market Cap Growth
45.32%19.91%1387.38%-64.51%--
Enterprise Value
63753829-
Last Close Price
0.470.460.540.210.60-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
28.1444.00----
PS Ratio
2.993.6410.93---
PB Ratio
1.541.452.071.874.42-
P/TBV Ratio
3.603.504.611.874.42-
P/FCF Ratio
1905.0639.58536.42---
P/OCF Ratio
356.4437.85506.85---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.283.616.54---
EV/FCF Ratio
1458.1539.34321.02---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.090.03---
Debt / FCF Ratio
103.092.378.07---
Net Debt / Equity Ratio
-0.37-0.41-0.39-0.99-1.01-1.01
Net Debt / EBITDA Ratio
74.8951.458.86---
Net Debt / FCF Ratio
-456.07-11.12-101.064.3222.74-622.24
Asset Turnover
0.550.420.31---
Inventory Turnover
6.886.27----
Quick Ratio
6.534.677.7948.54166.0137.20
Current Ratio
7.365.158.5950.24166.0137.98
Return on Equity (ROE)
-2.51%-3.43%-6.40%-18.85%-28.02%-
Return on Assets (ROA)
-1.65%-1.54%-5.29%-14.29%-18.85%-
Return on Capital Employed (ROCE)
-2.20%-2.10%-4.70%-25.40%-20.70%-8.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.30%-1.95%-1.60%-11.05%-4.31%-
FCF Yield
0.05%2.53%0.19%-12.20%-1.00%-
Buyback Yield / Dilution
-31.90%-53.12%-303.02%-1.39%-23.69%-